These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21968264)

  • 1. Understanding and treating opioid addiction in a patient with cancer pain.
    Kircher S; Zacny J; Apfelbaum SM; Passik S; Kirsch K; Burbage M; Lofwall M
    J Pain; 2011 Oct; 12(10):1025-31. PubMed ID: 21968264
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexmedetomidine for co-analgesia in chemotherapy-induced severe enterocolitis.
    Winton P; Whyte E; Reimer EJ; Davis J; Whyte S
    Paediatr Anaesth; 2011 Sep; 21(9):980-1. PubMed ID: 21793978
    [No Abstract]   [Full Text] [Related]  

  • 3. Navigating clinical care at the intersection of pain and addiction.
    Krupnick SL
    Medsurg Nurs; 2009; 18(6):381-4. PubMed ID: 20088194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pain therapy in patients with tumors. According to graduated schedule and hourly plan].
    MMW Fortschr Med; 2003 Oct; 145(40):53. PubMed ID: 14603608
    [No Abstract]   [Full Text] [Related]  

  • 5. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
    Resegotti L; Falda M; Rossi M; Infelise VE
    Panminerva Med; 1973 Sep; 15(9):275-7. PubMed ID: 4533778
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous acute myeloid leukaemia and de novo acute hepatitis B: a novel management strategy.
    Parrish C; Moreton P; Ashcroft J
    Leuk Res; 2011 Jun; 35(6):e67-8. PubMed ID: 21168208
    [No Abstract]   [Full Text] [Related]  

  • 8. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
    Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
    Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study].
    Sittig HB
    MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):95-8. PubMed ID: 15662898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of hydromorphone in pain killing].
    Telekes A
    Lege Artis Med; 2008 Oct; 18(10):675-9. PubMed ID: 19227610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydromorphone-OROS formulation.
    Goforth HW
    Expert Opin Pharmacother; 2010 May; 11(7):1207-14. PubMed ID: 20402557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exceptionally high narcotic analgesic requirements in a terminally ill cancer patient.
    Lo SL; Coleman RR
    Clin Pharm; 1986 Oct; 5(10):828-32. PubMed ID: 2430752
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pain therapy with semisynthetic opioids. Patients have opioid-type side effects more rarely].
    Sohn W
    MMW Fortschr Med; 2003 Jul; 145(27-28):50. PubMed ID: 14587190
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydromorphone.
    Murray A; Hagen NA
    J Pain Symptom Manage; 2005 May; 29(5 Suppl):S57-66. PubMed ID: 15907647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pain therapy. Extensive possibilities not adequately utilized].
    MMW Fortschr Med; 2005 May; 147(19):60-1. PubMed ID: 15940943
    [No Abstract]   [Full Text] [Related]  

  • 17. [New opioid preparations in the treatment of pain].
    Kalso E
    Duodecim; 1999; 115(20):2211-4. PubMed ID: 11973924
    [No Abstract]   [Full Text] [Related]  

  • 18. [Observational data in elderly pain patients show that fear of opioid therapy is unfounded].
    Junker U; Figge V
    MMW Fortschr Med; 2005 Jul; 147(27-28):43. PubMed ID: 16041941
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydromorphone.
    Pasero C; McCaffery M
    Am J Nurs; 2001 Feb; 101(2):22-3. PubMed ID: 11227223
    [No Abstract]   [Full Text] [Related]  

  • 20. OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs.
    Coluzzi F; Mattia C
    Minerva Anestesiol; 2010 Dec; 76(12):1072-84. PubMed ID: 21102402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.